{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T10:08:35Z","timestamp":1747303715106,"version":"3.40.5"},"reference-count":62,"publisher":"Bentham Science Publishers Ltd.","issue":"4","license":[{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/legalcode"}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["RRCT"],"published-print":{"date-parts":[[2021,1,12]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Critical hypoxia in this COVID-19 pandemic results in high mortality and\neconomic loss worldwide. Initially, this disease\u2019 pathophysiology was poorly understood and interpreted\nas a SARS (Severe Acute Respiratory Syndrome) pneumonia. The severe atypical lung CAT\nscan images alerted all countries, including the poorest, to purchase lacking sophisticated ventilators.\nHowever, up to 88% of the patients on ventilators lost their lives. It was suggested that\nCOVID-19 could be similar to a High-Altitude Pulmonary Edema (HAPE). New observations and\npathological findings are gradually clarifying the disease.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>As high-altitude medicine and hypoxia physiology specialists working and living in the\nhighlands for over 50 years, we perform a perspective analysis of hypoxic diseases treated at high\naltitudes and compare them to Covid-19. Oxygen transport physiology, SARS-Cov-2 characteristics,\nand its transmission, lung imaging in COVID-19, and HAPE, as well as the causes of clinical\nsigns and symptoms, are discussed.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>High-altitude oxygen transport physiology has been systematically ignored. COVID-19\nsigns and symptoms indicate a progressive and irreversible failure in the oxygen transport system,\nsecondary to pneumolysis produced by SARS-Cov-2\u2019s alveolar-capillary membrane \u201cattack\u201d.\nHAPE\u2019s pulmonary compromise is treatable and reversible. COVID-19 is associated with several\ndiseases, with different individual outcomes, in different countries, and at different altitudes.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions:<\/jats:title>\n<jats:p>The pathophysiology of High-altitude illnesses can help explain COVID-19 pathophysiology,\nseverity, and management. Early diagnosis and use of EPO, acetylsalicylic-acid, and\nother anti-inflammatories, oxygen therapy, antitussives, antibiotics, and the use of Earth open-circuit-\nastronaut-resembling suits to return to daily activities, should all be considered. Ventilator use\ncan be counterproductive. Immunity development is the only feasible long-term survival tool.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1574887115666200925141108","type":"journal-article","created":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T05:50:28Z","timestamp":1601272228000},"page":"347-359","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["COVID-19 and Pneumolysis Simulating Extreme High-altitude Exposure with Altered Oxygen Transport Physiology; Multiple Diseases, and Scarce Need of Ventilators: Andean Condor's-eye-view"],"prefix":"10.2174","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4283-6514","authenticated-orcid":true,"given":"Gustavo","family":"Zubieta-Calleja","sequence":"first","affiliation":[{"name":"High Altitude Pulmonary and Pathology Institute (HAPPI-IPPA), Av. Copacabana - Prolongacion # 55, La Paz, Bolivia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Zubieta-DeUrioste","sequence":"additional","affiliation":[{"name":"High Altitude Pulmonary and Pathology Institute (HAPPI-IPPA), Av. Copacabana - Prolongacion # 55, La Paz, Bolivia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thuppil","family":"Venkatesh","sequence":"additional","affiliation":[{"name":"High Altitude Pulmonary and Pathology Institute (HAPPI-IPPA), Av. Copacabana - Prolongacion # 55, La Paz, Bolivia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kusal K.","family":"Das","sequence":"additional","affiliation":[{"name":"High Altitude Pulmonary and Pathology Institute (HAPPI-IPPA), Av. Copacabana - Prolongacion # 55, La Paz, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Soliz","sequence":"additional","affiliation":[{"name":"High Altitude Pulmonary and Pathology Institute (HAPPI-IPPA), Av. Copacabana - Prolongacion # 55, La Paz, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"84","DOI":"10.2174\/1574887115999200228100745","volume":"15","author":"Gentile I.","year":"2020","unstructured":"Gentile I.; Abenavoli L.; COVID-19: Perspectives on the potential novel global threat. Rev Recent Clin Trials 2020,15(2),84-86","journal-title":"Rev Recent Clin Trials"},{"year":"2020","unstructured":"Our World in Data Case Fatality Rate on the ongoing COVID-19 pandemic 2020","key":"ref=2"},{"year":"2020","author":"Zubieta-Calleja G.R.","unstructured":"Zubieta-Calleja G.R.; Co-Vid-19 pandemia essential suggestions 2020","key":"ref=3"},{"key":"ref=4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.6775","author":"Richardson S.","year":"2020","unstructured":"Richardson S.; Hirsch J.S.; Narasimhan M.; Crawford J.M.; McGinn T.; Davidson K.W.; Barnaby D.P.; Becker L.B.; Chelico J.D.; Cohen S.L.; Cookingham J.; Coppa K.; Diefenbach M.A.; Dominello A.J.; Duer-Hefele J.; Falzon L.; Gitlin J.; Hajizadeh N.; Harvin T.G.; Hirschwerk D.A.; Kim E.J.; Kozel Z.M.; Marrast L.M.; Mogavero J.N.; Osorio G.A.; Qiu M.; Zanos T.P.; Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA and the Northwell COVID-19 Research Consortium2020","journal-title":"JAMA"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"632","DOI":"10.2967\/jnumed.120.246256","volume":"61","author":"Albano D.","year":"2020","unstructured":"Albano D.; Bertagna F.; Bertoli M.; Bosio G.; Lucchini S.; Motta F.; Panarotto M.B.; Peli A.; Camoni L.; Bengel F.M.; Giubbini R.; Incidental findings suggestive of covid-19 in asymptomatic patients undergoing nuclear medicine procedures in a high prevalence region. J Nucl Med 2020,61(5),632-636","journal-title":"J Nucl Med"},{"key":"ref=6","author":"Haeck G.","year":"2020","unstructured":"Haeck G.; Ancion A.; Marechal P.; Oury C.; Lancellotti P.;  Rev Med Liege [COVID-19 andcardiovascular diseases].2020","journal-title":"Rev Med Liege"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s12020-020-02294-5","volume":"68","author":"Puig-Domingo M.","year":"2020","unstructured":"Puig-Domingo M.; Marazuela M.; Giustina A.; COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology. Endocrine 2020,68(1),2-5","journal-title":"Endocrine"},{"key":"ref=8","author":"Prasad S.","year":"2020","unstructured":"Prasad S.; Potdar V.; Cherian S.; Abraham P.; Basu A.; Ransmission electron microscopy imaging of SARS-CoV-2 The Indian journal of medical research India 2020","journal-title":"The Indian journal of medical research India"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"105730","DOI":"10.1016\/j.envint.2020.105730","volume":"139","author":"Morawska L.","year":"2020","unstructured":"Morawska L.; Cao J.; Airborne transmission of SARS-CoV-2: The world should face the reality. Environ Int 2020,139,105730","journal-title":"Environ Int"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/infdis\/jiaa274","volume":"222","author":"Ratnesar-Shumate S.","year":"2020","unstructured":"Ratnesar-Shumate S.; Williams G.; Green B.; Krause M.; Holland B.; Wood S.; Bohannon J.; Boydston J.; Freeburger D.; Hooper I.; Beck K.; Yeager J.; Altamura L.A.; Biryukov J.; Yolitz J.; Schuit M.; Wahl V.; Hevey M.; Dabisch P.; Simulated Sunlight Rapidly Inactivates SARS-CoV-2 on Surfaces. J Infect Dis 2020,222(2),214-222","journal-title":"J Infect Dis"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1056\/NEJMc2004973","volume":"382","author":"van Doremalen N.","year":"2020","unstructured":"van Doremalen N.; Bushmaker T.; Morris D.H.; Holbrook M.G.; Gamble A.; Williamson B.N.; Tamin A.; Harcourt J.L.; Thornburg N.J.; Gerber S.I.; Lloyd-Smith J.O.; de Wit E.; Munster V.J.; Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med 2020,382(16),1564-1567","journal-title":"N Engl J Med"},{"year":"2009","author":"Decker F.","unstructured":"Decker F.; Electrochemistry encyclopedia 2009","key":"ref=12"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"103443","DOI":"10.1016\/j.resp.2020.103443","volume":"277","author":"Arias-Reyes C.","year":"2020","unstructured":"Arias-Reyes C.; Zubieta-DeUrioste N.; Poma-Machicao L.; Aliaga-Raduan F.; Carvajal-Rodriguez F.; Dutschmann M.; Schneider-Gasser E.M.; Zubieta-Calleja G.; Soliz J.; Does the pathogenesis of SARS-CoV-2 virus decrease at high-altitude? Respir Physiol Neurobiol 2020,277,103443","journal-title":"Respir Physiol Neurobiol"},{"author":"Zubieta-Calleja G.","unstructured":"Zubieta-Calleja G.;  The advantages of ultraviolet radiation in controlling the coronavirus at high altitude","journal-title":"The advantages of ultraviolet radiation in controlling the coronavirus at high altitude","key":"ref=14"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40249-020-00646-x","volume":"9","author":"Adhikari S.P.","year":"2020","unstructured":"Adhikari S.P.; Meng S.; Wu Y.J.; Mao Y.P.; Ye R.X.; Wang Q.Z.; Sun C.; Sylvia S.; Rozelle S.; Raat H.; Zhou H.; Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: A scoping review. Infect Dis Poverty 2020,9(1),29","journal-title":"Infect Dis Poverty"},{"key":"ref=16","author":"Li H","year":"2020","unstructured":"Li H; Liu L; Zhang D; SARS-CoV-2 and viral sepsis: Observations and hypotheses Lancet 2020","journal-title":"Lancet"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.007","volume":"220","author":"Magro C.","year":"2020","unstructured":"Magro C.; Mulvey J.J.; Berlin D.; Nuovo G.; Salvatore S.; Harp J.; Baxter-Stoltzfus A.; Laurence J.; Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases. Transl Res 2020,220,1-13","journal-title":"Transl Res"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1093\/ajcp\/aqaa062","volume":"153","author":"Barton L.M.","year":"2020","unstructured":"Barton L.M.; Duval E.J.; Stroberg E.; Ghosh S.; Mukhopadhyay S.; COVID-19 Autopsies, Oklahoma, USA. Am J Clin Pathol 2020,153(6),725-733","journal-title":"Am J Clin Pathol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1152\/japplphysiol.01167.2004","volume":"98","author":"B\u00e4rtsch P.","year":"2005","unstructured":"B\u00e4rtsch P.; Mairb\u00e4url H.; Maggiorini M.; Swenson E.R.; Physiological aspects of high-altitude pulmonary edema. J Appl Physiol 2005,98(3),1101-1110","journal-title":"J Appl Physiol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"e105114","DOI":"10.15252\/embj.20105114","volume":"39","author":"Lukassen S.","year":"2020","unstructured":"Lukassen S.; Chua R.L.; Trefzer T.; Kahn N.C.; Schneider M.A.; Muley T.; Winter H.; Meister M.; Veith C.; Boots A.W.; Hennig B.P.; Kreuter M.; Conrad C.; Eils R.; SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells. EMBO J 2020,39(10),e105114","journal-title":"EMBO J"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41368-020-0074-x","volume":"12","author":"Xu H.","year":"2020","unstructured":"Xu H.; Zhong L.; Deng J.; Peng J.; Dan H.; Zeng X.; Li T.; Chen Q.; High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci 2020,12(1),8","journal-title":"Int J Oral Sci"},{"key":"ref=22","doi-asserted-by":"publisher","DOI":"10.1002\/lary.28692","author":"Vaira L.A.","year":"2020","unstructured":"Vaira L.A.; Salzano G.; Deiana G.; De Riu G.; Anosmia and ageusia: common findings in COVID-19 patients. Laryngoscope 2020","journal-title":"Laryngoscope"},{"key":"ref=23","author":"Kannan S.","year":"2020","unstructured":"Kannan S.; Shaik Syed Ali P.; Sheeza A.; Hemalatha K.; COVID-19 (Novel Coronavirus 2019) - recent trends. Eur Rev Med Pharmacol Sci 2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=24","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00331.2008","author":"Lovren F.","year":"2008","unstructured":"Lovren F.; Pan Y.; Quan A.;  Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis 2008","journal-title":"Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis"},{"key":"ref=25","author":"Rubio R.","year":"2017","unstructured":"Rubio R.; Knabb M.;  Endothelial luminal membrane-glycocalyx: Functionalities in health and disease 2017","journal-title":"Endothelial luminal membrane-glycocalyx: Functionalities in health and disease"},{"key":"ref=26","author":"Zubieta-Calleja G.R.","year":"1989","unstructured":"Zubieta-Calleja G.R.; Zubieta-Castillo G.;  High altitude pathology at 12,000 ft 1989","journal-title":"High altitude pathology at 12,000 ft"},{"key":"ref=27","first-page":"347","author":"Zubieta-Castillo G.","year":"2007","unstructured":"Zubieta-Castillo G.; Zubieta-Calleja G.R.;  Adaptation Biology and Medicine 2007,347-355","journal-title":"Adaptation Biology and Medicine"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s00134-016-4611-1","volume":"43","author":"Nin N.","year":"2017","unstructured":"Nin N.; Muriel A.; Pe\u00f1uelas O.; Brochard L.; Lorente J.A.; Ferguson N.D.; Raymondos K.; R\u00edos F.; Violi D.A.; Thille A.W.; Gonz\u00e1lez M.; Villagomez A.J.; Hurtado J.; Davies A.R.; Du B.; Maggiore S.M.; Soto L.; D\u2019Empaire G.; Matamis D.; Abroug F.; Moreno R.P.; Soares M.A.; Arabi Y.; Sandi F.; Jibaja M.; Amin P.; Koh Y.; Kuiper M.A.; B\u00fclow H.H.; Zeggwagh A.A.; Anzueto A.; Sznajder J.I.; Esteban A.; Severe hypercapnia and outcome of mechanically ventilated patients with moderate or severe acute respiratory distress syndrome. Intensive Care Med VENTILA Group2017,43(2),200-208","journal-title":"Intensive Care Med"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s13054-020-02880-z","volume":"24","author":"Gattinoni L.","year":"2020","unstructured":"Gattinoni L.; Chiumello D.; Rossi S.; COVID-19 pneumonia: ARDS or not? Crit Care 2020,24(1),154","journal-title":"Crit Care"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"e7343","DOI":"10.7759\/cureus.7343","volume":"12","author":"Solaimanzadeh I.","year":"2020","unstructured":"Solaimanzadeh I.; Acetazolamide, nifedipine and phosphodiesterase inhibitors: Rationale for their utilization as adjunctive countermeasures in the treatment of coronavirus disease 2019 (COVID-19). Cureus 2020,12(3),e7343","journal-title":"Cureus"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1089\/ham.2016.0100","volume":"18","author":"Ebert-Santos C.","year":"2017","unstructured":"Ebert-Santos C.; High-Altitude pulmonary edema in mountain community residents. High Alt Med Biol 2017,18(3),278-284","journal-title":"High Alt Med Biol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/978-1-4615-4711-2_7","volume":"474","author":"Gibbs J.S.","year":"1999","unstructured":"Gibbs J.S.; Pulmonary hemodynamics: implications for high altitude pulmonary edema (HAPE). A review. Adv Exp Med Biol 1999,474,81-91","journal-title":"Adv Exp Med Biol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1148\/radiol.2020200230","volume":"295","author":"Chung M.","year":"2020","unstructured":"Chung M.; Bernheim A.; Mei X.; Zhang N.; Huang M.; Zeng X.; Cui J.; Xu W.; Yang Y.; Fayad Z.A.; Jacobi A.; Li K.; Li S.; Shan H.; CT imaging features of 2019 novel coronavirus (2019-NCoV). Radiology 2020,295(1),202-207","journal-title":"Radiology"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa2015432","volume":"383","author":"Ackermann M.","year":"2020","unstructured":"Ackermann M.; Verleden S.E.; Kuehnel M.; Haverich A.; Welte T.; Laenger F.; Vanstapel A.; Werlein C.; Stark H.; Tzankov A.; Li W.W.; Li V.W.; Mentzer S.J.; Jonigk D.; Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. N Engl J Med 2020,383(2),120-128","journal-title":"N Engl J Med"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1580\/1080-6032(1996)007[0127:TOHAPE]2.3.CO;2","volume":"7","author":"Zafren K.","year":"1996","unstructured":"Zafren K.; Reeves J.T.; Schoene R.; Treatment of high-altitude pulmonary edema by bed rest and supplemental oxygen. Wilderness Environ Med 1996,7(2),127-132","journal-title":"Wilderness Environ Med"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1378\/chest.45.3.273","volume":"45","author":"Marticorena E.","year":"1964","unstructured":"Marticorena E.; Tapia F.A.; Dyer J.; Severino J.; Banchero N.; Gamboa R.; Kruger H.; Penaloza D.; Pulmonary edema by ascending to high altitudes. Dis Chest 1964,45,273-283","journal-title":"Dis Chest"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.wem.2018.12.009","volume":"30","author":"Dawadi S.","year":"2019","unstructured":"Dawadi S.; Adhikari S.; Successful Summit of Two 8000 m Peaks After Recent High Altitude Pulmonary Edema. Wilderness Environ Med 2019,30(2),195-198","journal-title":"Wilderness Environ Med"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00392-020-01626-9","volume":"109","author":"Li B.","year":"2020","unstructured":"Li B.; Yang J.; Zhao F.; Zhi L.; Wang X.; Liu L.; Bi Z.; Zhao Y.; Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol 2020,109(5),531-538","journal-title":"Clin Res Cardiol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00395-020-0791-5","volume":"115","author":"Rizzo P.","year":"2020","unstructured":"Rizzo P.; Vieceli Dalla Sega F.; Fortini F.; Marracino L.; Rapezzi C.; Ferrari R.; COVID-19 in the heart and the lungs: Could we \u201cNotch\u201d the inflammatory storm? Basic Res Cardiol 2020,115(3),31","journal-title":"Basic Res Cardiol"},{"key":"ref=40","first-page":"431","volume":"57","author":"Zubieta-Castillo G.","year":"2006","unstructured":"Zubieta-Castillo G.; Zubieta-Calleja G.R.; Zubieta-Calleja L.; Chronic mountain sickness: The reaction of physical disorders to chronic hypoxia. J Physiol Pharmacol 2006,57(Suppl. 4),431-442","journal-title":"J Physiol Pharmacol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1016\/j.jacc.2020.04.031","volume":"75","author":"Bikdeli B.","year":"2020","unstructured":"Bikdeli B.; Madhavan M.V.; Jimenez D.; Chuich T.; Dreyfus I.; Driggin E.; Nigoghossian C.; Ageno W.; Madjid M.; Guo Y.; Tang L.V.; Hu Y.; Giri J.; Cushman M.; Qu\u00e9r\u00e9 I.; Dimakakos E.P.; Gibson C.M.; Lippi G.; Favaloro E.J.; Fareed J.; Caprini J.A.; Tafur A.J.; Burton J.R.; Francese D.P.; Wang E.Y.; Falanga A.; McLintock C.; Hunt B.J.; Spyropoulos A.C.; Barnes G.D.; Eikelboom J.W.; Weinberg I.; Schulman S.; Carrier M.; Piazza G.; Beckman J.A.; Steg P.G.; Stone G.W.; Rosenkranz S.; Goldhaber S.Z.; Parikh S.A.; Monreal M.; Krumholz H.M.; Konstantinides S.V.; Weitz J.I.; Lip G.Y.H.; COVID-19 and thrombotic or thromboembolic disease: Implications for prevention, antithrombotic therapy, and follow-Up: JACC state-of-the-art review. J Am Coll Cardiol Global COVID-19 thrombosis collaborative group, endorsed by the ISTH, NATF, ESVM, and the IUA, supported by the ESC working group on pulmonary circulation and right ventricular function2020,75(23),2950-2973","journal-title":"J Am Coll Cardiol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"268","DOI":"10.34172\/aim.2020.09","volume":"23","author":"Huang X.","year":"2020","unstructured":"Huang X.; Wei F.; Hu L.; Wen L.; Chen K.; Epidemiology and clinical characteristics of COVID-19. Arch Iran Med 2020,23(4),268-271","journal-title":"Arch Iran Med"},{"year":"1995","unstructured":"August  Bodil Schmidt-Nielsen1995","journal-title":"August","key":"ref=43"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"241569","DOI":"10.1155\/2013\/241569","volume":"2013","author":"San T.","year":"2013","unstructured":"San T.; Polat S.; Cingi C.; Eskiizmir G.; Oghan F.; Cakir B.; Effects of high altitude on sleep and respiratory system and theirs adaptations. ScientificWorldJournal 2013,2013,241569","journal-title":"ScientificWorldJournal"},{"key":"ref=45","volume":"343","author":"Zubieta-Calleja G.","year":"1998","unstructured":"Zubieta-Calleja G.; Zubieta-Castillo G.; Changes in oximery during breath holding in normal residents of hIgh altitude (3510m) Ohno H, Kobayashi T, Shigeru M, Nakashima M, editors Progress in Mountain Medicine and HIgh Altitude Physiology Press Committe of the 3rd World Congress on Mountain Medicine and High Altitude Physiology 1998,343-8","journal-title":"Ohno H, Kobayashi T, Shigeru M, Nakashima M, editors Progress in Mountain Medicine and HIgh Altitude Physiology Press Committe of the 3rd World Congress on Mountain Medicine and High Altitude Physiology"},{"key":"ref=46","first-page":"251","volume":"56","author":"Zubieta-Calleja G.R.","year":"2005","unstructured":"Zubieta-Calleja G.R.; Zubieta-Castillo G.; Paulev P.E.; Zubieta-Calleja L.; Non-invasive measurement of circulation time using pulse oximetry during breath holding in chronic hypoxia. J Physiol Pharmacol 2005,56(Suppl. 4),251-256","journal-title":"J Physiol Pharmacol"},{"key":"ref=47","first-page":"811","volume":"58","author":"Zubieta-Calleja G.R.","year":"2007","unstructured":"Zubieta-Calleja G.R.; Paulev P.E.; Zubieta-Calleja L.; Zubieta-Castillo G.; Altitude adaptation through hematocrit changes. J Physiol Pharmacol 2007,58(Pt 2)(Suppl. 5),811-818","journal-title":"J Physiol Pharmacol"},{"key":"ref=48","first-page":"65","volume":"Vol. 59","author":"Zubieta-Calleja G.R.","year":"2013","unstructured":"Zubieta-Calleja G.R.; Ardaya G.; Zubieta N.; Paulev P.E.;  Z-CG Tolerance to hypoxia Internet2013,Vol. 59,65-71","journal-title":"Z-CG Tolerance to hypoxia"},{"key":"ref=49","first-page":"155","volume":"56","author":"Paulev P.E.","year":"2005","unstructured":"Paulev P.E.; Zubieta-Calleja G.R.; Essentials in the diagnosis of acid-base disorders and their high altitude application. J Physiol Pharmacol 2005,56(Suppl. 4),155-170","journal-title":"J Physiol Pharmacol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s12291-010-0088-9","volume":"26","author":"Zubieta-Calleja G.","year":"2011","unstructured":"Zubieta-Calleja G.; Zubieta-Castillo G.; Zubieta-Calleja L.; Ardaya-Zubieta G.; Paulev P.E.; Do over 200 million healthy altitude residents really suffer from chronic Acid-base disorders? Indian J Clin Biochem 2011,26(1),62-65","journal-title":"Indian J Clin Biochem"},{"key":"ref=51","first-page":"18","volume":"37","author":"Vera O.","year":"1991","unstructured":"Vera O.; Valores normales de gases sanguineos arteriales y del equilibrio acido-base en la ciudad de La Paz, Bolivia. Cuad del Hosp Clin 1991,37(1),18-27","journal-title":"Cuad del Hosp Clin"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1016\/j.ajem.2020.04.048","volume":"38","author":"Long B.","year":"2020","unstructured":"Long B.; Brady W.J.; Koyfman A.; Gottlieb M.; Cardiovascular complications in COVID-19. Am J Emerg Med 2020,38(7),1504-1507","journal-title":"Am J Emerg Med"},{"key":"ref=53","author":"Tobin M.J.","year":"2012","unstructured":"Tobin M.J.; Laghi F.; Jubran A.;  Comprehensive Physiology 2012","journal-title":"Comprehensive Physiology"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/jmv.25839","volume":"92","author":"Hadadi A.","year":"2020","unstructured":"Hadadi A.; Mortezazadeh M.; Kolahdouzan K.; Alavian G.; Does recombinant human erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects? J Med Virol 2020,92(7),915-918","journal-title":"J Med Virol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1113\/jphysiol.2005.093328","volume":"568","author":"Soliz J.","year":"2005","unstructured":"Soliz J.; Joseph V.; Soulage C.; Becskei C.; Vogel J.; Pequignot J.M.; Ogunshola O.; Gassmann M.; Erythropoietin regulates hypoxic ventilation in mice by interacting with brainstem and carotid bodies. J Physiol 2005,568(Pt 2),559-571","journal-title":"J Physiol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"103476","DOI":"10.1016\/j.resp.2020.103476","volume":"279","author":"Soliz J.","year":"2020","unstructured":"Soliz J.; Schneider-Gasser E.M.; Arias-Reyes C.; Aliaga-Raduan F.; Poma-Machicao L.; Zubieta-Calleja G.; Furuya W.I.; Trevizan-Ba\u00fa P.; Dhingra R.R.; Dutschmann M.; Coping with hypoxemia: Could erythropoietin (EPO) be an adjuvant treatment of COVID-19? Respir Physiol Neurobiol 2020,279,103476","journal-title":"Respir Physiol Neurobiol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s10020-020-00186-y","volume":"26","author":"Ehrenreich H.","year":"2020","unstructured":"Ehrenreich H.; Weissenborn K.; Begemann M.; Busch M.; Vieta E.; Miskowiak K.W.; Erythropoietin as candidate for supportive treatment of severe COVID-19. Mol Med 2020,26(1),58","journal-title":"Mol Med"},{"key":"ref=58","first-page":"349","author":"Zubieta-Castillo G.","year":"1998","unstructured":"Zubieta-Castillo G.; Zubieta-Calleja G.; Zubieta-Calleja L.; Pulse oximetry in chronic mountain sickness - long breath holding time","journal-title":"Ohno H, Kobayashi T, Masuyama S, Nakashima Mi, editors Progress in Mountain Medicine and High Altitude Physiology Matsumoto: Press Committe of the 3rd World Congress on Mountain Medicine and High Altitude Physiology"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1182\/blood-2004-02-0744","volume":"104","author":"Beleslin-Cokic B.B.","year":"2004","unstructured":"Beleslin-Cokic B.B.; Cokic V.P.; Yu X.; Weksler B.B.; Schechter A.N.; Noguchi C.T.; Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells. Blood 2004,104(7),2073-2080","journal-title":"Blood"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ydbio.2004.08.025","volume":"276","author":"Kertesz N.","year":"2004","unstructured":"Kertesz N.; Wu J.; Chen T.H.P.; Sucov H.M.; Wu H.; The role of erythropoietin in regulating angiogenesis. Dev Biol 2004,276(1),101-110","journal-title":"Dev Biol"},{"key":"ref=61","first-page":"143","volume":"28","year":"2020","unstructured":"Lombardy Section Italian Society Infectious And Tropical Diseases -. Vademecum for the treatment of people with COVID-19 Edition 20, 13 March 2020 Le Infez Med 2020,28(2),143-52","journal-title":"Edition 20, 13 March 2020 Le Infez Med"},{"key":"ref=62","doi-asserted-by":"publisher","DOI":"10.1007\/s12291-020-00935-0","year":"2020","unstructured":"Zubieta-Calleja, G., Zubieta-DeUrioste, N. Pneumolysis and \u201cSilent Hypoxemia\u201d in COVID-19. Ind J Clin Biochem 2020","journal-title":"Ind J Clin Biochem"}],"container-title":["Reviews on Recent Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/186294","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/186294\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/186294","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T05:53:31Z","timestamp":1628056411000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/186294\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,12]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,1,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1574887115666200925141108","relation":{},"ISSN":["1574-8871"],"issn-type":[{"type":"print","value":"1574-8871"}],"subject":[],"published":{"date-parts":[[2021,1,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-05-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-03","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}